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S U M M A R Y
Objectives: This study was performed to investigate the molecular characterization of methicillin-
resistant Staphylococcus aureus (MRSA) isolated from the anterior nares of Korean children attending
daycare centers.
Methods: During September and October 2008, a survey of nasal carriage of MRSA was conducted among
healthy children who were attending daycare centers in Seoul, Korea. Nasal swab samples were cultured
to isolate S. aureus, and antimicrobial susceptibility was assessed using a disk diffusion test. All MRSA
isolates were archived for subsequent molecular tests, including multilocus sequence typing, Panton–
Valentine leukocidin (PVL) genes polymerase chain reaction (PCR), and staphylococcal cassette
chromosome mec (SCCmec) typing.
Results: Among 428 preschool-aged children enrolled, 9.3% (40/428) were colonized with MRSA. Among
the 40 MRSA isolates, antibiotic susceptibilities to clindamycin and erythromycin were 97.5% (39/40) and
45% (18/40), respectively. All of the 21 strains susceptible to clindamycin and resistant to erythromycin
had MLSB-inducible phenotypes. Sequence type (ST) 72–SCCmec type IV was the predominant clone
(n = 23; 57.5%), followed by ST72–SCCmec type II (n = 6; 15%), ST1765–SCCmec type IV (n = 4; 10%),
ST1765–SCCmec type II (n = 2; 5%), and ST1–SCCmec type IV (n = 2; 5%). No clone was positive for PVL
genes.
Conclusions: ST72 strains, which were previously found in hospital-associated MRSA, are now widely
distributed in healthy Korean children. In addition, the prevalence of inducible resistance of clindamycin
should be considered when selecting empirical antibiotics for community-associated MRSA infections in
Korea.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Since the 1990s, many studies have reported a signiﬁcant
prevalence of community-associated (CA) methicillin-resistant
Staphylococcus aureus (MRSA) colonization or infection.1 Severe
pneumonia and death associated with CA-MRSA infections are
frequently reported in the USA.2 In Korea, studies focusing on the
clinical signiﬁcance and burden of CA-MRSA infections among
healthy children have rarely been reported; however, 9.3% of§ This manuscript was presented in part at the 48th Annual Meeting of the
Infectious Diseases Society of America, Vancouver, British Columbia, Canada,
October 21–24, 2010.
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1201-9712/$36.00 – see front matter  2011 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.04.010healthy Korean children were found to be colonized with CA-
MRSA,3 and MRSA was found to account for 30.2% of community-
acquired S. aureus infections in our institute.4
CA-MRSA infections typically occur in patients without
established risk factors for healthcare-associated MRSA (HA-
MRSA), including recent hospitalization, surgery, or residence in
long-term care.5 Recently, however, CA-MRSA strains have been
reported in both the community and in healthcare settings.6
Molecular characterization, such as pulsed-ﬁeld gel electrophore-
sis (PFGE) and multilocus sequence typing (MLST), allow the
genotypes of CA-MRSA to be distinguished from HA-MRSA. CA-
MRSA isolates are usually represented by sequence type (ST) 8
(which encompasses USA300 clone by PFGE) and ST1 (USA400 by
PFGE) in the USA.7,8
The prevalence of MRSA carriage is diverse and depends upon
multiple factors, including age, environment, and geographicses. Published by Elsevier Ltd. All rights reserved.
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aureus colonization,9 and nasal carriage of S. aureus is an important
risk factor for sepsis. Carriers have higher rates of nosocomial S.
aureus bacteremia than non-carriers,10 and a large proportion of
nosocomial S. aureus infections originates from the patients’ own
ﬂora.11 Therefore, it is important to determine the prevalence of
CA-MRSA carriage among healthy Korean children in order to
estimate the potential burden of CA-MRSA infections in the
community setting.
Recently published studies on CA-MRSA isolates obtained from
Korean children suggest the presence of different molecular types
and a unique evolution of CA-MRSA in Korea compared to Western
countries.12,13 However, studies on the prevalence and molecular
characterization of colonized MRSA among Korean children have
been based on patients who required hospital visits or medical
treatment. Very few community-based studies evaluating the
prevalence of MRSA carriage and molecular characterization have
been performed in Korea.
We conducted this study to determine the molecular charac-
terization of MRSA isolated from community settings among
Korean children by MLST, staphylococcal cassette chromosome
mec (SCCmec) typing, and toxin gene assays using the Panton–
Valentine leukocidin (PVL) genes. In addition, antibiotic suscepti-
bility was analyzed to identify the optimal empirical antibiotics for
the treatment of potential CA-MRSA infections in Korean children.
2. Materials and methods
2.1. Study participants and bacterial strains
This was a point-prevalence study conducted in seven different
daycare centers located in the northern areas of Seoul, Korea. From
September to October 2008, 428 preschool-aged children with a
mean age of 55 months (range 12 months to 6.8 years), who
attended these daycare centers and who were apparently healthy,
were enrolled. This study was approved by the Institutional Review
Board of Seoul National University Hospital. Informed consent was
obtained from the children’s parents or guardians.
Specimens for culture were obtained from both anterior nares
with a sterile, wet cotton swab. Each swab was immediately placed
in an enrichment broth, processed in a microbiology laboratory
within 2 h of sampling, and incubated at 35 8C overnight. The
enrichment broth for S. aureus contained 37.5 g NaCl, 1.25 g yeast
extract, 5.0 g tryptone, and 500 ml distilled water. Each 10 ml of
incubated enrichment broth was inoculated in mannitol salt agar
(Bosung Science, Seoul, Korea), which is selective for S. aureus, and
incubated at 35 8C for 24–48 h; yellow colonies were selected and
conﬁrmed to be S. aureus following catalase, coagulase, and DNAse
tests.3 Nasal screening identiﬁed 164 (38.3%) S. aureus carriers,
including 40 (9.3%) MRSA and 124 (29.0%) methicillin-sensitive S.
aureus (MSSA) carriers.3 As a part of this study, the prevalence of
MRSA carriage among healthy Korean children attending daycare
centers has been published.3
2.2. Antimicrobial susceptibility testing
Antimicrobial susceptibility was determined according to the
guidelines of the Clinical and Laboratory Standards Institute;14
isolates that were resistant to oxacillin or cefoxitin were
considered to be MRSA. Susceptibility to penicillin G, oxacillin,
clindamycin, erythromycin, gentamicin, vancomycin, tetracycline,
ciproﬂoxacin, rifampin, and trimethoprim/sulfamethoxazole
(TMP/SMX) was determined using the disk diffusion method. In
vitro macrolide–lincosamide–streptogramin B (MLSB)-inducible
phenotypes were detected by the D-zone test (double-disk
diffusion test).152.3. MLST and Based Upon Related Sequence Types (eBURST) analysis
MLST was performed for all MRSA isolates by polymerase chain
reaction (PCR) and sequencing of seven housekeeping genes (arcC,
aroE, glpF, gmk, pta, tpi, and yqiL) using primers designed by Enright
et al.16 Each sequence was submitted to the MLST database
website (http://saureus.mlst.net) for assignment of an allelic
proﬁle and ST. To understand the evolution and population
structure of MRSA in Korea, some of the MSSA isolates that were
obtained from patients included in our study sample were also
analyzed by MLST.
The allelic proﬁles of S. aureus isolates were compared using the
eBURST program to infer patterns of evolutionary descent of S.
aureus isolates from the putative ancestral allelic proﬁle or clonal
complex (CC). These data are available at http://saureus.mlst.net/
eburst.
2.4. SCCmec typing
All MRSA isolates were typed to identify SCCmec, which is the
heterologous, mobile genetic element that carries the mecA gene
that encodes methicillin resistance. SCCmec typing of isolates and
PCR for the mecA gene was conducted following a multiplex PCR
strategy described by Milheiric¸o et al.17 Control strains for SCCmec
types I, II, III, IV, V, and IV were as follows: type I, COL;17 type II,
BK2464;18 type III, ANS46;17 type IV, MW2;17 type V, WIS;17 type
VI, HDE288.17
2.5. MRSA clones
MRSA clones were deﬁned by both their genotype (ST) and their
SCCmec type as proposed by Enright et al.19
2.6. Identiﬁcation of the PVL genes by PCR
PCR ampliﬁcation of genes encoding for PVL was performed for
all MRSA isolates and for some MSSA isolates included in the MLST
analysis, in accordance with the method described by Lina et al.20
3. Results
3.1. Molecular characterization of MRSA isolates
All 40 MRSA isolates were positive for the mecA gene. The
results of SCCmec typing demonstrated that SCCmec type IV (80%;
32/40) was the most common type, followed by SCCmec type II
(20%; 8/40). The PVL genes were not present in any of the 40 MRSA
isolates.
The most frequently detected ST of MRSA isolates was ST72
(n = 29), followed by ST1765 (n = 6), which was a single-locus
variant (SLV) of ST72 and was newly assigned in this study. The
remaining STs – ST1735, ST1736, and ST1737 –were newly
assigned STs, all of which were SCCmec type IV.
Overall, ST72–SCCmec type IV was the predominant clone
(n = 23; 57.5%) among MRSA colonization isolates, followed by
ST72–SCCmec type II (n = 6; 15%), ST1765–SCCmec type IV (n = 4;
10%), ST1765–SCCmec type II (n = 2; 5%), and ST1–SCCmec type IV
(n = 2; 5%) (Table 1).
3.2. Molecular characterization of MSSA isolates
To compare STs of MSSA and MRSA isolates, MLST was
performed on 20 randomly selected isolates from among our
124 MSSA isolates. The most frequently detected ST in those tested
was ST30 (n = 8), followed by ST72 (n = 3), ST6 (n = 2), and ST580
(n = 2) (Table 2). ST1, ST188, ST1738, ST1753, and ST1754 were
Table 1
Genotypes of 40 MRSA colonization isolates and phenotypes of clindamycin resistance according to each genotype
MRSA clones Erythromycin-resistant MLSB-inducible Clindamycin-resistant Presumably clindamycin resistant
a
Overall (n = 40) 55% (22/40) 100% (21/21) 2.5% (1/40) 55% (22/40)
ST72–SCCmec IV (57.5%; 23/40) 60.9% (14/23) 100% (14/14) 0% (0/23) 60.9% (14/23)
ST72–SCCmec II (15%; 6/40) 66.7% (4/6) 100% (4/4) 0% (0/6) 66.7% (4/6)
ST1765–SCCmec IV (10%; 4/40) 50% (2/4) 100% (2/2) 0% (0/4) 50% (2/4)
ST1765–SCCmec II (5%; 2/40) 0% (0/2) NA 0% (0/2) 0% (0/2)
ST1–SCCmec IV (5%; 2/40) 0% (0/2) NA 0% (0/2) 0% (0/2)
ST1735b–SCCmec IV (2.5%; 1/40) 100% (1/1) 100% (1/1) 0% (0/1) 100% (1/1)
ST1736b–SCCmec IV (2.5%; 1/40) 100% (1/1) NA 100% (1/1) NA
ST1737b–SCCmec IV (2.5%; 1/40) 0% (0/1) NA 0% (0/1) NA
MRSA, methicillin-resistant Staphylococcus aureus; MLSB, macrolide–lincosamide–streptogramin B; NA, not applicable.
a The presumed clindamycin resistance rate was calculated based on the results of the D-zone test; only one MRSA isolate, for which the genotype was ST1736–SCCmec
type IV, had an MLSB-constitutive phenotype as determined by the D-zone test.
b These were newly detected STs in this study.
Table 2
Phenotypes of clindamycin resistance of the MSSA colonization isolates according to each sequence type (ST)a
MSSA clones Erythromycin-resistant MLSB-inducible Clindamycin-resistant Presumably clindamycin-resistant
b
Overall (n = 124) 40.3% (50/124) 95.9% (47/49) 0.8% (1/124) 38.7% (48/124)
ST30 (n = 8) 62.5% (5/8) 100% (5/5) 0% (0/8) 62.5% (5/8)
ST72 (n = 3) 33.3% (1/3) 100% (1/1) 0% (0/3) 33.3% (1/3)
ST580 (n = 2) 0% (0/2) NA 0% (0/2) 0% (0/2)
ST6 (n = 2) 50% (1/2) 100% (1/1) 0% (0/2) 50% (1/2)
ST1 (n = 1) 0% (0/1) NA 0% (0/1) 0% (0/1)
ST188 (n = 1) 0% (0/1) NA 0% (0/1) 0% (0/1)
ST1738c (n = 1) 100% (1/1) 100% (1/1) 0% (0/1) 100% (1/1)
ST1753c (n = 1) 0% (0/1) NA 0% (0/1) 0% (0/1)
ST1754c (n = 1) 0% (0/1) NA 0% (0/1) 0% (0/1)
MSSA, methicillin-sensitive Staphylococcus aureus; MLSB, macrolide–lincosamide–streptogramin B; NA, not applicable; MLST, multilocus sequence typing.
a MLST was performed on only 20 randomly selected isolates among the 124 MSSA colonization isolates.
b The presumed clindamycin resistance rate was calculated based on the results of the D-zone test; only one MSSA isolate, for which the genotype was not determined in
this study, had an MLSB-constitutive phenotype.
c These were newly detected STs in this study.
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detected in this study. We did not detect the PVL genes in the 20
MSSA isolates tested.
3.3. eBURST analyses of 40 MRSA and 20 MSSA isolates
Only ﬁve clonal groups were identiﬁed among the 60 tested S.
aureus isolates (Figure 1): CC8 (65%; 39/60), CC30 (15%; 9/60),
CC15 (8.3%; 5/60), CC6 (3.3%; 2/60), and CC509 (1.7%; 1/60). Four S.
aureus isolates that did not belong to the speciﬁc CCs were also
identiﬁed. CC8 was the major clonal group among S. aureus in this
carriage study, which included ST72 and its SLVs, ST1765 and
ST1754. This clonal group included most of the heterogeneous
genotypes. ST72 and ST1765 were observed in both MSSA and
MRSA isolates, some of which contained not only SCCmec type IV,
but also SCCmec type II. However, MRSA isolates from the other CCs
contained only SCCmec type IV.
CC30 was the second largest clonal group, and most of these
were ST30-MSSA (n = 8), which was the major genotype among
MSSA colonization isolates in this study. Only one MRSA isolate
with a genotype of ST1737–SCCmec type IV, which is a double-
locus variant of ST30, was observed in the CC30 group.
3.4. Antibiotic susceptibility proﬁles among 40 MRSA isolates
Antimicrobial susceptibility testing results of 40 MRSA are
shown in Table 3. All 40 MRSA isolates were fully susceptible to
vancomycin, rifampin, tetracycline, and TMP/SMX. Among the 40
MRSA isolates, antibiotic susceptibilities to clindamycin and
erythromycin were 97.5% (39/40) and 45% (18/40), respectively.
All of the 21 strains susceptible to clindamycin and resistant to
erythromycin had MLSB-inducible phenotypes. Only one MRSAisolate, for which the genotype was ST1736–SCCmec type IV, had
an MLSB-constitutive phenotype, as determined by the D-zone test
(Table 1). MRSA isolates with genotypes ST1765–SCCmec type II,
ST1–SCCmec type IV, and ST1737–SCCmec type IV were fully
susceptible to both erythromycin and clindamycin.
3.5. Antibiotic susceptibility proﬁles among 124 MSSA isolates
The antimicrobial susceptibility patterns of 124 MSSA isolates
are presented in Table 3. Of the erythromycin-resistant and
clindamycin-susceptible MSSA isolates, the double-disk diffusion
test was positive in 95.9% (47/49), which had MLSB-inducible
phenotypes. Only one MSSA isolate had an MLSB-constitutive
phenotype (Table 2).
4. Discussion
In Korea, outbreaks of CA-MRSA infection among children and
adolescents have not yet been detected, except in clustered cases
of staphylococcal scaled-skin syndromes in Kyungsangnamdo
Province of Korea.13 However, CA-MRSA has already spread and
become an important pathogen among Korean children. For
example, almost one-third of community-acquired S. aureus
infections are caused by MRSA and, in particular, 86.2% of
community-acquired staphylococcal skin and soft-tissue infec-
tions (SSTI) are caused by MRSA at our institute.4 A study on
genotypic characteristics of MRSA isolates obtained from neonatal
patients suggested that CA-MRSA strains had spread in primary
care clinics in Seoul, Korea.21
MLST is an appropriate method for molecular typing that could
identify the evolution of CA-MRSA to determine the ancestral
phylogeny of the staphylococcal population.19 The evolutionary
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Figure 1. Schematic model for the evolution of Staphylococcus aureus in clonal complex (CC) 8, CC15, CC30, CC6, and CC509. The collection of 60 S. aureus isolates, including 40
MRSA isolates and 20 MSSA isolates, was analyzed by eBURST and included in this model. Abbreviations: SLV (single-locus variant), DLV (double-locus variant).
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makes it possible to speculate on the likely evolutionary relation-
ships among bacterial clones in conjunction with the analysis of
SCCmec types.19 Although ﬁve clonal groups – CC5, CC8, CC22,
CC30, and CC45 – are known to cause the majority of pandemic
MRSA worldwide,19 geographic variations are present among
circulating CA-MRSA strains. In the USA, CA-MRSA of genotypes
ST8 and ST1 have emerged as the major circulating strains.8,22,23
ST80 is prevalent in Europe,24 and STs 1, 8, and 30 are frequently
found in Australia as CA-MRSA isolates.25 Although the epidemic
CA-MRSA clones in Asian countries have been reported less often,
ST89 and ST8 were found to be predominant in Japanese CA-MRSA
isolates and ST59 in Taiwanese isolates.1,26,27
The ST72-MRSA clone was obtained from both community
surveillance and a hospital-acquired outbreak and belonged to CC8.8
Even though ST72 is known to be a major CA-MRSA clone in
Korea,12,13,28 the molecular data for CA-MRSA colonization amongTable 3
Antimicrobial non-susceptibilities of 40 MRSA and 124 MSSA colonization isolates obt
Antibiotic N
M
Penicillin 4
Oxacillin or cefoxitin 4
Vancomycin 0
Clindamycinb 1
Erythromycin 2
Trimethoprim/sulfamethoxazole 0
Gentamicin 8
Ciproﬂoxacin 8
Rifampin 0
Chloramphenicol 0
Tetracycline 0
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylo
a Antibiotic isolates that were intermediately susceptible and resistant were categor
b The presumed clindamycin resistance based on detection of inducible clindamycin re
38.7% (48/124) among MSSA isolates.healthy young children attending daycare centers have not been
reported so far to our knowledge. This active surveillance study
conﬁrmed that CA-MRSA isolates of genotype ST72 and its SLV
ST1765 also prevailed in the community of healthy preschool-aged
children in Seoul, Korea, with a carriage rate of 8.2% (35/428). In
addition, genotypes ST1 and ST8 were rarely or never detected as CA-
MRSA clones in this study, both of which were predominant
genotypes in the USA. Likewise, ST1 and ST8 were also not detected
among healthy children as an MRSA colonizer in a Taiwanese study.1
Although SCCmec type IV was the predominant type in this
community-based study, SCCmec type II, which is known to be
associated with HA-MRSA isolates, was detected in up to 20% of
MRSA isolates. In this study, two MRSA isolates were obtained from
children with risk factors for healthcare-associated infections,3 but
could not be distinguished from the other CA-MRSA isolates based
on their molecular characterization. Both of them belonged to the
most frequently detected genotype of ST72–SCCmec type IV andained from healthy children attending daycare centers in Korea
o. of non-susceptible strainsa (% of non-susceptibility)
RSA (n = 40) MSSA (n = 124)
0 (100) 121 (97.6)
0 (100) 0 (0)
 (0) 0 (0)
 (2.5) 1 (0.8)
2 (55) 50 (40.3)
 (0) 0 (0)
 (20) 6 (4.8)
 (20) 1 (0.8)
 (0) 0 (0)
 (0) 2 (1.6)
 (0) 6 (4.8)
coccus aureus.
ized as non-susceptible.
sistance using the D-zone test was as follows: 55% (22/40) among MRSA isolates and
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isolates with a multidrug resistance phenotype were frequently
observed among the presumed CA-MRSA infection cases of Korean
children.4 These ﬁndings would imply that a mix-up of CA- and
HA-MRSA has already occurred in Korea. In the same context,
SCCmec type II, which has been considered a marker for HA-MRSA,
was frequently detected in CA-MRSA nasal isolates in our study.
Among MSSA colonization isolates tested, more diverse STs were
observed and ST30 was the predominant genotype. Because only a
limited number of MSSA isolates was included in the MLST
analysis, there was a limitation in our ability to determine the
evolutionary relationship between MSSA and MRSA clones.
PVL genes, which are known to be associated with necrosis of
the skin, severe necrotizing pneumonia, and abscess formation, are
frequently detected in MRSA isolates deriving from community-
associated infections in the USA and Europe.7,29 Even though our
study included only a small number of isolates, PVL genes were not
found in any of the isolates. This result is similar to those observed
in other studies from Korea and Taiwan.1,12,13
CA-MRSA isolates are usually susceptible to clindamycin and
less often have multiple resistance to other non-b-lactam
antibiotics.29 Among the CA-MRSA isolates in our study, resistance
was typically limited to b-lactams and erythromycin, and the
frequency of in vitro clindamycin resistance was only 2.5% (1/40).
However, all MRSA isolates susceptible to clindamycin and
resistant to erythromycin showed MLSB-inducible phenotypes.
The MLSB-inducible phenotype was more prevalent than the MLSB-
constitutive phenotype among MRSA colonization isolates, which
was discordant with the ﬁndings of another Asian study.1 Although
clindamycin might still be effective in some cases with inducible
clindamycin-resistant organisms, occasional treatment failures
have been documented for the MRSA infection with an MLSB-
inducible phenotype.30,31 Therefore, the use of clindamycin as an
empirical antibiotic for the treatment of CA-MRSA infections in
Korean children should be considered carefully, and clindamycin
resistance among CA-MRSA isolates should be monitored contin-
uously. Although vancomycin is superior to TMP/SMX for the
treatment of S. aureus infections, TMP/SMX may be considered in
selected cases of MRSA infection.32 TMP/SMX-resistant S. aureus
isolates were not observed in our study, and TMP/SMX would be a
possible option for minor infections caused by CA-MRSA in Korea.
There were limitations to our study. First, this was a point-
prevalence study; as a result, it was impossible to discriminate the
persistent MRSA carriers from the intermittent carriers. Persistent
carriers have higher S. aureus loads and a higher risk of acquiring S.
aureus infections than non-carriers or intermittent carriers.33,34
Further studies including MRSA isolates obtained from persistent
carriers might result in more appropriate data with clinical
relevance. Second, our investigation was performed in a restricted
area in Seoul, Korea, and the number of isolates included was
relatively small. Therefore, our ﬁndings may not reﬂect the patterns
of MRSA across the entire country, where circulating strain types
might differ. Third, relatively high antibiotic pressure even on
healthy children in Korea might have inﬂuenced the resistance
patterns and molecular epidemiology of CA-MRSA, such as a high
prevalence of SCCmec type II. However, the exact impact of
antibiotics on this study population could not be evaluated due to
recall limitations of the parents of the study participants.
In conclusion, the predominant STs, prevalence of PVL genes, and
antibiotic susceptibility patterns among CA-MRSA isolates in Korea
were clearly different from those reported in other countries.
Continuous monitoring of MRSA colonization and antibiotic
susceptibility should be mandatory. Further studies focusing on
the molecular characterization of carriage and clinical isolates of CA-
and HA-MRSA would provide informative data for revealing the
current burden and evolution of CA-MRSA in Korea.Acknowledgement
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